Repositrak, Inc. (TRAK) - 10-Q Summary
Business Context and Reporting Period
Company: Repositrak, Inc. (formerly Park City Group, Inc.)
Reporting Period: Quarter and nine months ended March 31, 2026 (Fiscal Year 2026)
Business Model: B2B SaaS provider offering compliance, traceability, and supply chain management solutions for the food industry. The company operates on a "hub and spoke" model, engaging retailers who mandate supplier participation.
Key Drivers: Regulatory compliance with FSMA 204(d) traceability rules and retailer mandates for supply chain visibility.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2026 | Nine Months Ended Mar 31, 2026 | Nine Months Ended Mar 31, 2025 |
|---|---|---|---|
| Revenue | $5.88 million | $17.71 million | $16.85 million |
| Net Income | $1.99 million | $5.49 million | $5.18 million |
| Diluted EPS | $0.10 | $0.28 | $0.26 |
| Operating Cash Flow (9mo) | $5.86 million | ||
| Cash & Equivalents (Mar 31, 2026) | $26.41 million | ||
| Total Debt | $0.35 million (Leases only; no bank debt) | ||
| Working Capital | $26.34 million |
Material Changes vs. Prior Period
- Revenue Growth: Nine-month revenue increased 5% year-over-year ($17.71M vs. $16.85M), driven by recurring subscription growth in compliance and traceability lines. Quarterly revenue was flat (-1%) due to timing of onboarding fees.
- Profitability: Operating income increased to $2.25 million for the quarter (up from $1.81 million) and $5.96 million for the nine months (up from $4.64 million). Gross margins improved as Cost of Revenue decreased 12% quarterly and 9% annually due to capitalization of development costs.
- Expense Management: Sales and marketing expenses decreased 4% quarterly but increased 1% annually due to higher commissions. General and administrative expenses decreased 5% quarterly due to headcount reductions and lower lease costs.
- Investing Activity: Significant cash outflow of $3.0 million for the issuance of a note receivable to SPAR Marketing Force, Inc.
- Financing Activity: Continued share repurchases ($1.80 million in the nine months) and redemption of Series B Preferred Stock ($1.87 million).
Outlook, Risks, and Unusual Items
- Dividend Policy: The Board declared a quarterly cash dividend of $0.02 per share (annualized $0.08), representing a ~1.05% yield. The company has increased dividends three times since 2022.
- Preferred Stock Redemption: The company intends to redeem all remaining Series B Preferred Stock (approx. $1.72 million remaining) by December 2026.
- Unusual Item - Note Receivable: On March 17, 2026, the company issued a $3.0 million unsecured note to SPAR Marketing Force, Inc. at 8.0% interest. The deal includes equity consideration (1M shares of SPAR Group) and price protection provisions that may require derivative accounting (bifurcation) under ASC 815.
- Regulatory Environment: The FDA extended the FSMA 204 compliance deadline to July 2028, but commercial pressure from retailers is driving immediate adoption of traceability solutions.
- Interest Rate Risk: Declining interest rates are expected to reduce interest income on the company's substantial cash balances.
Investor Verification Checklist
- Derivative Accounting: Verify the final accounting treatment for the SPAR Marketing Force note, specifically the valuation and potential earnings impact of the embedded price protection derivative.
- Recurring Revenue Mix: Confirm the percentage of revenue derived from recurring subscriptions versus one-time setup fees to validate the sustainability of the 5% annual growth.
- Preferred Stock Timeline: Monitor the execution of the remaining $1.72 million preferred stock redemption to ensure it occurs by the stated December 2026 deadline.
- Credit Concentration: Assess the credit risk associated with the $3.0 million unsecured note receivable to a single borrower (SPAR Marketing Force).
- Capital Allocation: Review the balance between share buybacks, dividend payments, and potential R&D investment given the capitalization of development costs.